Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Rangering i aksjer #14551
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Aksjekurs
$0.87679425
Sist synkronisert: 2026-08-31
Markedsverdi
$407.66M
Endring (1 dag)
-1.88%
Endring (1 år)
58.03%
Land
SE
Handel Egetis Therapeutics AB (publ) (EGTX)

Kategori

Historikk for aksjesplitt for Egetis Therapeutics AB (publ) (EGTX)
Aksjen Egetis Therapeutics AB (publ) (symbol: EGTX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 01, 2026.
Én EGTX-aksje kjøpt før Sep 01, 2026 tilsvarer i dag 0 EGTX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH